IQVIA is trading 15.37% up at $246.45 after beating Q2 2026 earnings estimates and raising its full-year outlook.

  • The company reported $4.37 billion in revenue and $3.15 adjusted EPS, both exceeding analyst expectations, while R&D bookings reached a record $3.15 billion.
  • Management raised its 2026 adjusted EPS guidance to a range of $12.80–$13.00 and increased its revenue outlook, providing a clear catalyst for the stock's outperformance.